Myotonic dystrophy type 2 found in two of sixty-three persons diagnosed as having fibromyalgia

Arthritis and Rheumatism

Volumn 58, Issue 11, 2008, Pages 3627-3631

  Auvinen, Satu ^a   Suominen, Tiina ^b   Hannonen, Pekka ^a   Bachinski, Linda L ^c   Krahe, Ralf ^c   Udd, Bjarne ^d,e,f  

^a JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

^f VAASA CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FEMALE; FIBROMYALGIA; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOTONIC DYSTROPHY; MYOTONIC DYSTROPHY 2; PRIORITY JOURNAL;

AGED; DIAGNOSTIC ERRORS; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; MYOTONIC DYSTROPHY;

EID: 55849149758     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24037     Document Type: Article

References (17)

1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990;3:160-72.
2. Dadabhoy D, Clauw DJ. Therapy insight: fibromyalgia - a different type of pain needing a different type of treatment. Nature Clin Pract Rheumatol 2006;2:364-72.
3. Bengtsson A. The muscle in fibromyalgia [review]. Rheumatology (Oxford) 2002;41:721-4.
4. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
5. Harper PS. Myotonic dystrophy. 3rd ed. London: WB Saunders; 2001.
6. Brook JD, McCurrah ME, Harley HG, Buckler AJ, Church D, Aburatani H, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992;68:799-808.
7. Ricker K, Koch MC, Lehman-Horn F, Pongratz D, Speich N, Reiners K, et al. Proximal myotonic myopathy: clinical features of a multisystem disorder similar to myotonic dystrophy. Arch Neurol 1995;52:25-31.
8. Meola G, Sansone V, Radice S, Skradski S, Ptacek L. A family with an unusual myotonic and myopathic phenotype and no CTG expansion (proximal myotonic myopathy syndrome): a challenge for future molecular studies. Neuromuscul Disord 1996;6:143-50.
9. Udd B, Krahe R, Wallgren-Pettersson C, Falck B, Kalimo H. Proximal myotonic dystrophy - a family with autosomal dominant muscular dystrophy, cataracts, hearing loss and hypogonadism: heterogeneity of proximal myotonic disorders? Neuromuscul Disord 1997;7:217-28.
10. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001;293:864-7.
11. Udd B, Meola G, Krahe R, Thornton C, Ranum L, Day J, et al. Report of the 115th ENMC workshop: DM2/PROMM and other myotonic dystrophies. 3rd Workshop, 14-16 February 2003, Naarden, The Netherlands. Neuromuscul Disord 2003;3:589-96.
12. Udd B, Meola G, Krahe R,Thornton C, Ranum LP, Bassez G, et al. The140th ENMC International Workshop: myotonic dystrophy DM2/PROMM and other myotonic dystrophies with guidelines on management. Neuromuscul Disord 2006;16:403-13.
13. Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick A, Kress W, et al. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 2003;60:657-64.
14. Valkeinen H, Hakkinen A, Hannonen P, Hakkinen K, Alen M. Acute heavy-resistance exercise-induced pain and neuromuscular fatigue in elderly women with fibromyalgia and in healthy controls: effects of strength training. Arthritis Rheum 2006;54:1334-9.
15. Piippo K, Swan H, Pasternack M, Chapman H, Paavonen K, Viitasalo M, et al. A founder mutation of the potassium channel KCNQ1 in long QT syndrome: implications for estimation of disease prevalence and molecular diagnostics. J Am Coll Cardiol 2001;37:562-8.
16. Sallinen R, Vihola A, Bachinski LL, Huoponen K, Haapasalo H, Hackman P, et al. New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2). Neuromuscul Disord 2004;14:274-83.
17. Bachinski LL, Udd B, Meola G, Sansone V, Bassez G, Eymard B, et al. Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/ proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect. Am J Hum Genet 2003;73:835-48.